FULCRUM THERAPEUTICS INC (FULC)
US3596161097 - Common Stock
ChartMill assigns a Buy % Consensus number of 81% to FULC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.52. This target is 81.65% above the current price.
FULC was analyzed by 14 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about FULC.
In the previous month the buy percentage consensus was at a similar level.
FULC was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-13 | RBC Capital | Initiate | Outperform |
| 2024-02-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-01-26 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-01-25 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-09-25 | Goldman Sachs | Initiate | Neutral |
| 2023-08-23 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2023-08-22 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-08-22 | Stifel | Upgrade | Hold -> Buy |
| 2023-08-04 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-05-16 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-05-16 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2023-05-05 | Goldman Sachs | Maintains | Neutral |
| 2023-05-04 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2023-03-13 | Goldman Sachs | Maintains | Buy |
| 2023-03-10 | Credit Suisse | Downgrade | Outperform -> Neutral |
| 2023-03-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-03-10 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-02-28 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2023-02-28 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-27 | Oppenheimer | Maintains | Outperform |
| 2023-02-27 | Credit Suisse | Maintains | Outperform |
| 2023-02-27 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-24 | Morgan Stanley | Maintains | Overweight |
| 2023-01-23 | Piper Sandler | Maintains | Overweight |
| 2023-01-19 | Goldman Sachs | Maintains | Buy |
| 2022-11-15 | Goldman Sachs | Initiate | Buy |
| 2022-11-14 | Morgan Stanley | Maintains | Overweight |
| 2022-11-09 | Credit Suisse | Maintains | Outperform |
| 2022-06-13 | HC Wainwright & Co. | Maintains | Buy |